A detailed history of Webster Bank, N. A. transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Webster Bank, N. A. holds 28 shares of CRNX stock, worth $905. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28
Holding current value
$905
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 08, 2025

BUY
$25.56 - $33.76 $715 - $945
28 New
28 $0

Others Institutions Holding CRNX

About Crinetics Pharmaceuticals, Inc.


  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $1.74B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Webster Bank, N. A. Portfolio

Follow Webster Bank, N. A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Webster Bank, N. A., based on Form 13F filings with the SEC.

News

Stay updated on Webster Bank, N. A. with notifications on news.